Skip to main content
Patient with ray of light on undereye hollows shown after treatment with Restylane® Eyelight
Actual patient. Individual results may vary.

Awaken refreshed

Restylane® Eyelight helps improve undereye hollows, so you can look how you feel from the moment you open your eyes: refreshed and ready to face the day.1,2*
*≥76% of patients (clinical trial subjects) satisfied with their reduced undereye shadows and ≥79% looking less tired through 18 months with optimal treatment.
Patient at a window showing a smoother undereye area after treatment with Eyelight
Actual patient. Individual results may vary.

Exit shadows. Enter light.

Restylane Eyelight is an FDA-approved hyaluronic acid (HA) dermal filler formulated with NASHA® Technology, which has a firm gel texture resulting in targeted product placement, helping it stay in place.3-5 Restylane Eyelight fills in the undereye area to reduce shadows.1,2*
*≥76% of patients (clinical trial subjects) were satisfied with their reduced undereye shadows through 18 months with optimal treatment.

Explore more Before & After photos

Explore unretouched images of real people who chose Restylane for natural-looking results that are still true to them.
Restylane® Eyelight patient Michael before treatment
Restylane® Eyelight patient Michael after treatment
Michael was treated with 1 mL of Restylane Eyelight in the undereye hollows and 2 mL of Restylane Lyft in the cheeks. Two weeks after treatment. Actual patient. Individual results may vary.

Real people. Real results.

  • 93 %
    of patients* agreed that they had improved undereye hollows 18 months after optimal treatment.1†
  • ≥94 %
    of patients* would recommend Restylane Eyelight treatment to a friend when asked up to 18 months after optimal treatment.1
  • 9 in 10
    patients* thought their results looked natural when asked 18 months after optimal treatment.1
93 %
of patients* agreed that they had improved undereye hollows 18 months after optimal treatment.1†
≥94 %
of patients* would recommend Restylane Eyelight treatment to a friend when asked up to 18 months after optimal treatment.1
9 in 10
patients* thought their results looked natural when asked 18 months after optimal treatment.1
Restylane® Eyelight logo
*Patient=clinical trial subject.
Improvement evaluated according to the Global Aesthetic Improvement Scale (GAIS).

Frequently Asked Questions

Tired-looking eyes can have many causes but are often the result of volume loss under the eyes. People often describe the appearance of “dark circles” and “bags” under the eyes that make them look aged, tired, stressed, or sick as common motivators to seek treatment to correct the undereye area.1 In a clinical study, 87% of patients* thought they looked less tired 18 months after optimal treatment with Restylane Eyelight.2†

View our gallery of patient results.

References:
  • Data on file. Analysis of consumer social media conversation/digital behaviors. Galderma Laboratories, L.P. 2023.
  • Data on file. GLI.04.US.SL.024 Clinical Study Report. Galderma Laboratories, L.P. 2023.
*Patient=clinical trial subject.
Percentage very satisfied or satisfied with question.

Restylane Eyelight is Galderma’s safe and trusted product formulated with NASHA® Technology, which is close to the body’s naturally occurring HA with minimal crosslinking.1 Restylane Eyelight is a supportive gel that is resistant to water absorption, with minimized swelling effects.2,3

References:
  • Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35(suppl 1):302-312.
  • Data on file. MA-34483 Study Report. Galderma Laboratories, L.P. 2021.
  • Data on file. MA-53297 Study Report. Galderma Laboratories, L.P. 2022.

HA dermal fillers, like Restylane Eyelight, are commonly used to replace lost volume in the face.1 Dark shadows and hollows under the eyes can result in a tired and aged look.2 Restylane Eyelight fills in the undereye area to help people look more refreshed, while maintaining a natural look and feel.3,4*

References:
  • Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35(suppl 1):302-312.
  • Cleveland Clinic. Dark Circles Under Eyes. Cleveland Clinic Health Library. Updated May 25, 2022. Accessed April 2023. https://my.clevelandclinic.org/health/symptoms/23128-dark-circles-under-eyes
  • Restylane Eyelight. Instructions for Use. Galderma Laboratories, L.P., 2023.
  • Data on file. 43USTT1904 Clinical Study Report. Galderma Laboratories, L.P., 2022.
*87% of patients thought they looked less tired 18 months after optimal treatment with Restylane Eyelight.4‡ 92% of patients thought their results looked natural 18 months after optimal treatment.4
Patient=clinical trial subject.
Percentage very satisfied or satisfied with question.

Join ASPIRE Galderma Rewards to start earning points with qualifying treatments.

Every 100 points = $10 of valuable savings on more of the treatments along your aesthetic journey.

Sign up today and receive a $20 Welcome Reward* for your next treatment.

*Offer terms and conditions apply.

Find an aesthetic injector

Ready to take the next step? Browse aesthetic specialists near you to book a consultation, discuss your aesthetics goals, and get all your filler questions answered in person.

map
Map data ©2023 Google.

@RestylaneUSA

Actual patients. Individual results may vary.
References
  1. Data on file. 43USTT1904 Clinical Study Report. Galderma Laboratories, L.P. 2022.
  2. Restylane Eyelight. Instructions for Use. Galderma Laboratories, L.P., 2023.
  3. Data on file. MA-34483 Study Report. Galderma Laboratories, L.P. 2021.
  4. Lundgren B, Sandkvist U, Bordier N, et al. Using a new photo scale to compare product integration of different hyaluronan-based fillers after injection in human ex vivo skin. J Drugs Dermatol. 2018;17(9):982-986.
  5. Nikolis A, Chesnut C, Biesman B, et al. Expert recommendations on the use of hyaluronic acid filler for tear trough rejuvenation. J Drugs Dermatol. 2022;21(4):387-392.
  6. Nikolis A, Berros P, Enright KM, Cordoba M, Nguyen Q. A randomized, crossover-controlled evaluator-blinded trial evaluating cannula- vs needle-assisted hyaluronic acid injections for infraorbital deformities. Aesthet Surg J. 2022;42(3):285-297.
  7. Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg.
    2009;35(suppl 1):302-312.
Important Safety Information

The Restylane family of products are indicated for patients over the age of 21, and includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine, Restylane® Silk, Restylane® Kysse, Restylane® Refyne, Restylane® Defyne, Restylane® Contour, and Restylane® Eyelight.

Approved Uses

Restylane® and Restylane-L® are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane® and Restylane-L® are also indicated for injection into the lips.

Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies. Restylane® Lyft with Lidocaine is also indicated for injection into the dorsal hand to correct volume loss.

Restylane® Silk is for lip augmentation and for correction of perioral wrinkles.

Restylane® Kysse is for lip augmentation and for correction of upper perioral wrinkles.

Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds. Restylane® Defyne is also indicated for injection into the mid-to-deep dermis (subcutaneous and/or supraperiosteal) for augmentation of the chin region to improve the chin profile in patients with mild to moderate chin retrusion.

Restylane® Contour is for cheek augmentation and for the correction of midface contour deficiencies.

Restylane® Eyelight is for the improvement of infraorbital hollowing.

Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, prone to bleeding, or have a bleeding disorder. The safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders as these side effects can occur with hyaluronic acid fillers. Tell your doctor if you are planning other cosmetic treatments (i.e., lasers and chemical peels) as there is a possible risk of inflammation at the injection site.

Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Using these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete.

The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent including, vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.

To report a side effect with any Restylane® product, please call Galderma Laboratories, L.P at 1-855-425-8722.

To learn more about serious but rare side effects and full Important Safety Information, visit www.RestylaneUSA.com.

US-RES-2300327